160 related articles for article (PubMed ID: 33816613)
1. LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion.
Deng B; Pan R; Ou X; Wang T; Wang W; Nie Y; Chen H
Biomed Res Int; 2021; 2021():5271291. PubMed ID: 33816613
[TBL] [Abstract][Full Text] [Related]
2. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.
Dai JH; Huang WZ; Li C; Deng J; Lin SJ; Luo J
Cell Cycle; 2019 Oct; 18(20):2727-2741. PubMed ID: 31432728
[No Abstract] [Full Text] [Related]
3. LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101.
Yu CL; Xu NW; Jiang W; Zhang H; Ma Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7709-7717. PubMed ID: 32744697
[TBL] [Abstract][Full Text] [Related]
4. lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion.
Zha Z; Han Q; Liu W; Huo S
J Orthop Surg Res; 2020 Feb; 15(1):38. PubMed ID: 32013985
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
[TBL] [Abstract][Full Text] [Related]
6. LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma.
Luo XF; Wu XJ; Wei X; Wang AG; Wang SH; Wang JL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8751-8760. PubMed ID: 31696461
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA ADIRF antisense RNA 1 upregulates insulin receptor substrate 1 to decrease the aggressiveness of osteosarcoma by sponging microRNA-761.
Xu L; Tan Y; Xu F; Zhang Y
Bioengineered; 2022 Feb; 13(2):2028-2043. PubMed ID: 35030964
[TBL] [Abstract][Full Text] [Related]
8. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
[TBL] [Abstract][Full Text] [Related]
9.
Luo Y; Tao H; Jin L; Xiang W; Guo W
Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
[No Abstract] [Full Text] [Related]
10. Long Noncoding RNA SERTAD2-3 Inhibits Osteosarcoma Proliferation and Migration by Competitively Binding miR-29c.
Zhang Z; Liu J; Wu Y; Zhao X; Hao Y; Wang X; Xue C; Wang Y; Zhang R; Zhang X
Genet Test Mol Biomarkers; 2020 Feb; 24(2):67-72. PubMed ID: 31999493
[No Abstract] [Full Text] [Related]
11. Long Noncoding RNA HNF1A-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p/HMGB1 Axis.
Lou P; Ding T; Zhan X
Cancer Biother Radiopharm; 2021 May; 36(4):371-381. PubMed ID: 32706998
[No Abstract] [Full Text] [Related]
12. LncRNA SOX21-AS1 Promotes the Growth and Invasiveness of Osteosarcoma Cells Through miR-7-5p/IRS2 Regulatory Network.
Chen H; Chen J
Arch Med Res; 2021 Apr; 52(3):294-303. PubMed ID: 33341286
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA MNX1-AS1 promoted osteosarcoma proliferation and invasion via inhibiting KISS1.
Zhang YX; Cui HX; Liu L; Yi GK
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6045-6052. PubMed ID: 31364121
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
[TBL] [Abstract][Full Text] [Related]
15. LncRNA BE503655 inhibits osteosarcoma cell proliferation, invasion/migration via Wnt/β-catenin pathway.
Huang Q; Shi SY; Ji HB; Xing SX
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31316000
[No Abstract] [Full Text] [Related]
16. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.
Yu Y; Wang L; Li Z; Zheng Y; Shi Z; Wang G
J Biochem Mol Toxicol; 2021 May; 35(5):e22734. PubMed ID: 33522065
[TBL] [Abstract][Full Text] [Related]
17. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway.
Shi D; Wu F; Mu S; Hu B; Zhong B; Gao F; Qing X; Liu J; Zhang Z; Shao Z
J Exp Clin Cancer Res; 2019 Aug; 38(1):375. PubMed ID: 31443665
[TBL] [Abstract][Full Text] [Related]
18. lncRNA RBM5-AS1 promotes cell proliferation and invasion by epigenetically silencing miR-132/212 in hepatocellular carcinoma cells.
Mu JY; Tian JX; Chen YJ
Cell Biol Int; 2021 Nov; 45(11):2201-2210. PubMed ID: 34019714
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis.
Dai J; Xu LJ; Han GD; Jiang HT; Sun HL; Zhu GT; Tang XM
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S783-S790. PubMed ID: 30260245
[TBL] [Abstract][Full Text] [Related]
20. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
Zhou Y; Feng D; Gu X; Gao A; Liu Y
Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
